The Impact of Comorbidities and Clinical Characteristics on Real-World Mepolizumab Effectiveness in Patients with Severe Asthma: Results from the REALITI-A Study

被引：0
|
作者：
Chupp, G. L. [1 ]
Heaney, L. G. [2 ]
Pelaia, G. [3 ]
Welte, T. [4 ,5 ]
Sanchez, C. Almonacid [6 ]
Lee, J. K. [7 ]
Maxwell, A. [8 ]
Price, R. G. [9 ]
Jakes, R. W. [10 ]
Cristancho, R. Alfonso [11 ]
Howarth, P. [12 ]
Brusselle, G. [13 ]
机构：
[1] Yale Sch Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, New Haven, CT USA
[2] Queens Univ Belfast, Wellcome Wolfson Ctr Expt Med, Belfast, Antrim, North Ireland
[3] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy
[4] Hannover Med Sch, Dept Resp Med, Hannover, Germany
[5] Hannover Med Sch, German Ctr Lung Res, Hannover, Germany
[6] Toledo Univ Hosp, Castilla La Mancha Med Sch, Dept Resp Med, Toledo, Spain
[7] Toronto Allergy & Asthma Clin, Evidence Based Med Educ, Toronto, ON, Canada
[8] GSK, Real World Study Delivery, Value Evidence & Outcomes, Global Med, Stevenage, Herts, England
[9] GSK, Biostat, Stevenage, Herts, England
[10] GSK, Epidemiol, London, England
[11] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[12] GSK, Specialty Care TA, Global Med, Brentford, Middx, England
[13] Ghent Univ Hosp, Dept Resp Med, Ghent, Belgium
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
基金：
芬兰科学院;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4836
引用
收藏
页数：2
相关论文
共 50 条
  • [31] REAL-WORLD OUTCOMES WITH MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA ACCORDING TO SMOKING HISTORY AND COPD STATUS AT ENROLLMENT: REALITI-A POST HOC ANALYSIS
    Bagnasco, Diego
    Hill, David G.
    Welte, Tobias
    Chaudhuri, Rekha
    Price, Robert
    Howarth, Peter
    [J]. CHEST, 2023, 164 (04) : 75A - 76A
  • [32] Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: Post hoc analysis of realiti-a at 2 years
    Smith, A.
    Patel, M.
    Caruso, C.
    Pilette, C.
    Welte, T.
    Alfonso-Cristancho, R.
    Price, R. G.
    Howarth, P.
    [J]. ALLERGY, 2023, 78 : 50 - 51
  • [33] International, prospective study of mepolizumab in severe asthma: REALITI-A at 2yrs
    Caruso, C.
    Canonica, G. W.
    Patel, M.
    Smith, A.
    Liu, M. C.
    Alfonso-Cristancho, R.
    Price, R. G.
    Jakes, R. W.
    Demetriou, L.
    Valero, A.
    Pilette, C.
    Howarth, P.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [34] How Real-World Mepolizumab Users in the REALITI-A Study Relate to the Recruitment Criteria Applied in the Randomized, Placebo-Controlled Trials of Subcutaneous Mepolizumab in Severe Eosinophilic Asthma
    Ramos-Barbon, D.
    Bals, R.
    Crimi, N.
    Menzies, D.
    Pek, B.
    Pilette, C.
    Steven, G.
    Alfonso-Cristancho, R.
    Jakes, R.
    Maxwell, A. C.
    Price, R. G.
    Yang, S.
    Howarth, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [35] HEALTHCARE RESOURCE USE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA AFTER THE INITIATION OF MEPOLIZUMAB IN REAL-LIFE SETTINGS - REALITI-A STUDY
    Yang, S.
    Maxwell, A.
    Joksaite, S.
    Chaudhuri, R.
    Pastorello, E. A.
    Lee, J.
    Kohler, T. C.
    Ramos-Barbon, D.
    Schleich, F.
    Steven, G.
    Alfonso, R.
    [J]. VALUE IN HEALTH, 2020, 23 : S361 - S361
  • [36] Managing Patients with Severe Asthma and Common Comorbidities of Atopy, Obesity & Depression/Anxiety: Real-world Effectiveness of Mepolizumab
    Molfino, Nestor
    Casale, Thomas
    Silver, Jared
    Bogart, Michael
    Packnett, Elizabeth
    McMorrow, Donna
    Wu, Juan
    Hahn, Beth
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB56 - AB56
  • [37] UK severe asthma patient outcomes in the real-world versus Italy and the USA: REALITI-A at 2 years
    Weir, J.
    Egan, B.
    Heaney, L.
    Menzies, D.
    Pfeffer, P.
    Howarth, P.
    Chaudhuri, R.
    [J]. THORAX, 2023, 78 (SUPPL_4) : A184 - A184
  • [38] Managing patients with severe asthma and common comorbidities of atopy, obesity, and depression/anxiety: real-world effectiveness of mepolizumab
    Molfino, Nestor
    Casale, Thomas
    Silver, Jared
    Bogart, Michael
    Packnett, Elizabeth
    McMorrow, Donna
    Wu, Juan
    Hahn, Beth
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (01) : 87 - 87
  • [39] Mepolizumab Treatment Leads to Clinical Remission in Patients with Severe Eosinophilic Asthma: Results from the Real-World REDES Study
    Domingo Ribas, C.
    Pavord, I.
    Price, R. G.
    Howarth, P.
    Oppenheimer, J.
    Heaney, L.
    Nagase, H.
    Pizzichini, E.
    Banas Conejero, D.
    Gardiner, F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [40] Real World Benefits of Mepolizumab in Patients With Severe Asthma and Comorbid Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Post Hoc Analysis of REALITI-A
    Lee, Frances
    Liu, Mark
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Howarth, Peter
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB15 - AB15
12345